Karami Fath Mohsen, Azargoonjahromi Ali, Soofi Asma, Almasi Faezeh, Hosseinzadeh Shahnaz, Khalili Saeed, Sheikhi Kamran, Ferdousmakan Saeid, Owrangi Soroor, Fahimi Minoovash, Zalpoor Hamidreza, Nabi Afjadi Mohsen, Payandeh Zahra, Pourzardosht Navid
Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
Shiraz University of Medical Sciences, Shiraz, Iran.
Cancer Cell Int. 2022 Oct 12;22(1):313. doi: 10.1186/s12935-022-02738-0.
Melanoma is the most aggressive form of skin cancer resulting from genetic mutations in melanocytes. Several factors have been considered to be involved in melanoma progression, including genetic alteration, processes of damaged DNA repair, and changes in mechanisms of cell growth and proliferation. Epigenetics is the other factor with a crucial role in melanoma development. Epigenetic changes have become novel targets for treating patients suffering from melanoma. These changes can alter the expression of microRNAs and their interaction with target genes, which involves cell growth, differentiation, or even death. Given these circumstances, we conducted the present review to discuss the melanoma risk factors and represent the current knowledge about the factors related to its etiopathogenesis. Moreover, various epigenetic pathways, which are involved in melanoma progression, treatment, and chemo-resistance, as well as employed epigenetic factors as a solution to the problems, will be discussed in detail.
黑色素瘤是由黑素细胞基因突变导致的最具侵袭性的皮肤癌形式。几个因素被认为与黑色素瘤进展有关,包括基因改变、受损DNA修复过程以及细胞生长和增殖机制的变化。表观遗传学是在黑色素瘤发展中起关键作用的另一个因素。表观遗传变化已成为治疗黑色素瘤患者的新靶点。这些变化可改变微小RNA的表达及其与靶基因的相互作用,这涉及细胞生长、分化甚至死亡。鉴于这些情况,我们进行了本综述,以讨论黑色素瘤的危险因素,并介绍有关其发病机制相关因素的当前知识。此外,将详细讨论参与黑色素瘤进展、治疗和化疗耐药性的各种表观遗传途径,以及作为解决问题手段所采用的表观遗传因素。
Cancer Cell Int. 2022-10-12
Cancer Control. 2009-7
Immunotherapy. 2013-10
Lab Invest. 2014-6-30
Epigenomics. 2023-2
Curr Opin Oncol. 2015-9
Ochsner J. 2010
Cancers (Basel). 2022-11-28
Adv Exp Med Biol. 2008
Pharmaceuticals (Basel). 2025-6-6
Pigment Cell Melanoma Res. 2025-1
J Natl Cancer Cent. 2021-1-16
Infect Agent Cancer. 2022-7-18
Cell Mol Biol Lett. 2022-6-28
Nat Chem Biol. 2022-8
Cell Mol Biol Lett. 2022-4-9